| HEPLIQO NOVARTIS AG
1633723 03 Jul 2013 | on 05 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals | | | HEPLISAV DYNAVAX TECHNOLOGIES CORPORATION
1615048 21 Feb 2013 | on 19 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Human vaccines. | | | HEPLISAV-B DYNAVAX TECHNOLOGIES CORPORATION
1613607 11 Feb 2013 | on 19 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Human vaccines. | | | HEPLISAV DYNAVAX TECHNOLOGIES CORPORATION
1293726 15 Mar 2006 | on 03 Apr 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, vaccines for human use. | | | HEPLINE MEDTRONIC INC.
A CORPORATION OF MINNESOTA
878616 19 May 1998 | on 31 Dec 1969 | Class 001 Class 001 Chemical Products Class 010 Class 010 Medical Instrument Products Test kits to verify performance of coagulation instruments, cartridges and parts, components and fittings therefor. | | 
